Skip to content

Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus

Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01627184
Acronym
LUCID
Enrollment
13
Registered
2012-06-25
Start date
2012-05-31
Completion date
2013-06-30
Last updated
2015-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

The purpose of this study is to evaluate CGM glycemic control using the Dexcom G4 system as well as system performance during high levels of activity and home use by adult athletes with insulin-requiring diabetes mellitus, over an extended period of time.

Interventions

DEVICEDexcom G4 CGM System

Sponsors

DexCom, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 years or older 2. Diagnosis of diabetes mellitus

Exclusion criteria

1. Extensive skin changes/diseases 2. Known allergy to medical adhesives 3. Pregnancy 4. Dialysis

Design outcomes

Primary

MeasureTime frameDescription
Glycemic Control during Exercisemultiple months, up to 6The proportion of time spent in euglycemia zone as well as hypoglycemia zone will be determined from the system glucose readings, particularly during subject's high levels of activity. Longitudinal data analysis methods will be used to assess the within-subject and between-subject effects of the glycemic control for the study population.

Secondary

MeasureTime frameDescription
System Utility and Usabilitymultiple months, up to 6The objectives of the study are to evaluate the Dexcom G4 system utility and usability during high levels of activity and home use. The assessments may be evaluated by, but are not limited to, the following: * Number and duration of sensors used by subject * Percentage of CGM system communication during wear * Percentage of CGM system glucose reading during wear * Incidence of System prompts and error messages recorded in the receiver

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026